The Consortium for Clinical Research and Innovation Singapore (CRIS), a wholly-owned subsidiary of MOH Holdings, was established in 2020 with the goal of strengthening synergies and developing strategies for national-level clinical research and translation programmes that are under the stewardship of the Ministry of Health (MOH). CRIS brings together seven entities as business units under a common management and governance structure.
The Consortium for Clinical Research and Innovation Singapore (CRIS), a wholly-owned subsidiary of MOH Holdings, was established in 2020 with the goal of strengthening synergies and developing strategies for national-level clinical research and translation programmes that are under the stewardship of the Ministry of Health (MOH). CRIS brings together seven entities as business units under a common management and governance structure.
The Consortium for Clinical Research and Innovation Singapore (CRIS), a wholly-owned subsidiary of MOH Holdings, was established in 2020 with the goal of strengthening synergies and developing strategies for national-level clinical research and translation programmes that are under the stewardship of the Ministry of Health (MOH). CRIS brings together seven entities as business units under a common management and governance structure.